Clinical Trial

Registry on Luma Vision's VERAFEYE System (ENLIgHT)

Study acronym: ENLIgHT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to compile real-world data on the use of the VERAFEYE System in standard of care atrial fibrillation (AF) ablation procedures and left atrial appendage closure (LAAC) procedures.
Protocol Amendment History 8 changes
notable Primary completion pushed: 2027-09-15 -> 2027-10-15 2026-07-08
minor Completion pushed: 2027-09-15 -> 2027-10-15 2026-07-08
notable Primary completion pushed: 2027-08-15 -> 2027-09-15 2026-06-11
minor Completion pushed: 2027-08-15 -> 2027-09-15 2026-06-11
notable Primary completion pushed: 2027-07-15 -> 2027-08-15 2026-05-08
minor Completion pushed: 2027-07-15 -> 2027-08-15 2026-05-08
notable Primary completion pushed: 2027-06-15 -> 2027-07-15 2026-04-15
minor Completion pushed: 2027-06-15 -> 2027-07-15 2026-04-15
Trial Details
NCT Number NCT06293430
Lead Sponsor LUMA Vision Ltd.
Conditions Atrial Fibrillation, Left Atrial Appendage Closure, Atrial Arrhythmia
Enrollment 50 participants
Start Date 2027-02-15
Primary Completion 2027-10-15 (estimated)
Study Completion 2027-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-07